Author:
Badarudin Nurul Suhaida,Mohamed Shah Noraida,Mohd Tahir Nurul Ain,Ahmat Azmi Nor Mohd Farez,Ismail Fuad,Islahudin Farida,Yusak Suhana,Muhammad Syahir,Mohd Kassim Kamarun Neasa Begam
Reference39 articles.
1. Chemotherapy-induced nausea and vomiting: roles of pharmacists and formulary decision makers;McCullough;Am J Manag Care,2017
2. Chemotherapy-induced nausea and vomiting in clinical practice: impact on patients‘ quality of life;Fernández-Ortega;Support Care Cancer,2012
3. Chemotherapy-induced nausea and vomiting: optimizing prevention and management;Rao;Am Health Drug Benefits,2012
4. Is the EQ-5D suitable for use in oncology? An overview of the literature and recent developments;Schwenkglenks;Expert Rev Pharmacoecon Outcomes Res,2016
5. Baseline patient characteristics, incidence of CINV, and physician perception of CINV incidence following moderately and highly emetogenic chemotherapy in Asia Pacific countries;Hsieh;Support Care Cancer,2015